SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-24-006847
Filing Date
2024-12-10
Accepted
2024-12-10 08:00:29
Documents
16
Period of Report
2024-12-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_121024.htm   iXBRL 8-K 22608
2 EXHIBIT 10.1 exh_101.htm EX-10.1 86282
3 PRESS RELEASE exh_991.htm EX-99.1 6852
  Complete submission text file 0001171843-24-006847.txt   344730

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE gnw-20190101.xsd EX-101.SCH 3003
5 XBRL DEFINITION FILE gnw-20190101_def.xml EX-101.DEF 25598
6 XBRL LABEL FILE gnw-20190101_lab.xml EX-101.LAB 34011
7 XBRL PRESENTATION FILE gnw-20190101_pre.xml EX-101.PRE 22139
18 EXTRACTED XBRL INSTANCE DOCUMENT f8k_121024_htm.xml XML 3424
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Filer) CIK: 0001738021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39696 | Film No.: 241537157
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)